Aibotics Inc. (AIBT)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
-0.0010 (-50.00%)
Apr 29, 2026, 3:53 PM EST
Aibotics Revenue
In the year 2025, Aibotics had annual revenue of $2.18K.
Revenue
2.18K
Revenue Growth
n/a
P/S Ratio
415.44
Revenue / Employee
2.18K
Employees
1
Market Cap
906.92K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EV Biologics | 9.47M |
| Sorrento Therapeutics | 64.27M |
| Regenerative Medical Technology Group | 5.04M |
| CNBX Pharmaceuticals | 40.64K |
| Emmaus Life Sciences | 12.45M |
| SQZ Biotechnologies Company | 12.12M |
Aibotics News
- 1 year ago - Mycotopia Therapies Inc. Announces Name Change to AIBiotics, Inc. and Symbol Change to AIBT - GlobeNewsWire
- 1 year ago - AIBotics Provides 2025 Update; Strengthens Position in AI, Wellness, and Robotics - GlobeNewsWire
- 2 years ago - Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million - GlobeNewsWire
- 3 years ago - PSLY.com, Inc. Ei.Ventures, Inc. and Mycotopia Therapies Inc. Terminate Agreement and Plan of Merger - GlobeNewsWire
- 4 years ago - Mycotopia Therapies Inc. Update on Ei.Ventures and Strategic Investments - GlobeNewsWire
- 4 years ago - Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market - GlobeNewsWire
- 4 years ago - Mycotopia Therapies Inc. To Enter $13 Billion Medicinal Mushroom Market With HAVN Life Sciences' Biopharmaceuticals And Ei.Ventures MANA Products - GlobeNewsWire
- 4 years ago - Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc. - GlobeNewsWire